Bing Wang

Assoc Professor

1994 …2023
If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Bing Hui Wang trained in Chemistry (BSc and MSc) and gained a PhD in the Department of Biochemistry, La Trobe University. His post-doctoral research has been in the area of cellular signaling in cardiac vascular diseases. He was a senior research officer at the Baker Heart Research Institute for four years and involved in studies on the roles of adrenergic receptors in cardiac function and discovered inositol polyphosphate 1-phosphatase as a novel anti-hypertrophic factor.

He then changed his career to commercial research in biotechnology industry. During his research as the Senior Scientist and Head of the Molecular Biology Department, at Cytopia Pty Ltd he made substantial contributions to many of the patents and other intellectual properties.

In October, 2005, Dr Wang re-joined academic research by taking up a Senior Research Fellow position with Prof Henry Krum, Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University. Under the mentorship of Prof Krum, Dr Wang has made significant progress and contribution to academic research in the areas of cardiovascular pharmacology, drug discovery and development, and cardiorenal syndrome research. Dr Wang has expertise in molecular and cellular biology, biomarkers and protein biochemistry, drug design and development, natural products chemistry and pharmacology, especially in signaling mechanisms of inflammatory cytokines and mediators/biomarkers in cardiovascular and renal diseases including heart failure and chronic kidney diseases.

Education/Academic qualification

Biochemistry and Chemistry, PhD, La Trobe University

1 Feb 19931 Jul 1996

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2007 2023

Research Output 1994 2019

Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction

Kompa, A. R., Lu, J., Weller, T. J., Kelly, D. J., Krum, H., von Lueder, T. G. & Wang, B. H., 1 May 2018, In : International Journal of Cardiology. 258, p. 192-198 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage

Liu, S., Wang, B. H., Kelly, D., Krum, H. & Kompa, A. R., 1 Jan 2018, In : Journal of Cellular and Molecular Medicine. 22, 1, p. 628-645 18 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Efficacy of intra-articular injections of platelet-rich plasma as a symptom- and disease-modifying treatment for knee osteoarthritis - The RESTORE trial protocol

Paterson, K. L., Hunter, D. J., Metcalf, B. R., Eyles, J., Duong, V., Kazsa, J., Wang, Y., Buchbinder, R., Cicuttini, F., Forbes, A., Harris, A., Yu, S. P., Wang, B. H., Connell, D., Linklater, J. & Bennell, K. L., 28 Jul 2018, In : BMC Musculoskeletal Disorders. 19, 1, p. 272 11 p., 272.

Research output: Contribution to journalArticleOtherpeer-review

Open Access

Increased cardiomyocyte alignment and intracellular calcium transients using micropatterned and drug-releasing poly(glycerol sebacate) elastomers

Zhu, C., Rodda, A. E., Truong, V. X., Shi, Y., Zhou, K., Haynes, J. M., Wang, B., Cook, W. D. & Forsythe, J. S., 2018, In : ACS Biomaterials Science and Engineering. 4, 7, p. 2494-2504 11 p.

Research output: Contribution to journalArticleResearchpeer-review